Defining emerging markets for life sciences − “where to play”

Defining emerging markets for life sciences − “where to play”


Life Sciences | Pharmaceuticals

In this article, the first in a series of Insights where CRA discusses our perspective on emerging markets, we suggest a new way to define key emerging markets for the life sciences industry – “where to play.” The article can be found here.

Download PDF